Dr. de Weerd Pets SRL
Dr. de Weerd Pets reported total assets of 836,355 € at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Oct 2026).
The score of Dr. de Weerd Pets shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +8 % Total assets +10 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. de Weerd Pets's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Oct 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 13 Jul 2022
Dr. de Weerd Pets's financial analysis
- Solvency51.3%sector median: 45.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. de Weerd Pets
Dr. de Weerd Pets's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0740.602.918
- VAT number
- BE0740602918
- Peppol
- Registered · 0208:0740602918 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 31 Dec 2019
- Registered office
- 2930 Brasschaat
- Latest accounts
- 2025 · filed on 15 Oct 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Dr. de Weerd Pets (SRL) has been based in Brasschaat since 2019, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 5,462 € and equity of 428,870 €; its revenue is not published. Its solvency stands at 51.3%, above the median of its sector (45.8%).
Companies similar to Dr. de Weerd Pets
Companies in the same business, of comparable size and area, outside its group.
- Added Pharma International Wholesale of pharmaceutical and medical goods Schoten · balance sheet 308,424 €
- Honeypatch Manufacture of pharmaceutical preparations Liège · balance sheet 330,409 €
- Feton Wholesale of pharmaceutical and medical goods Uccle · balance sheet 806,088 €
- Medical Promotion Wholesale of pharmaceutical and medical goods Jodoigne · balance sheet 790,556 €
- Care FOR Health Wholesale of pharmaceutical and medical goods Ghent · balance sheet €1.00m
- Distriphar Wholesale of pharmaceutical and medical goods Brussels · balance sheet €1.09m
- L.F. Will et Cie Wholesale of pharmaceutical and medical goods Wavre · balance sheet €1.21m
- I&L Biosystems Belgium Wholesale of pharmaceutical and medical goods Leuven · balance sheet 576,883 €
Frequently asked questions about Dr. de Weerd Pets
What is the revenue of Dr. de Weerd Pets?
Dr. de Weerd Pets files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. de Weerd Pets?
In Belgium, the VAT number is the company number prefixed with BE: BE0740602918 for Dr. de Weerd Pets, if the company is VAT-registered. Its company number (CBE) is 0740.602.918.
Where is the registered office of Dr. de Weerd Pets?
According to the CBE register, the registered office of Dr. de Weerd Pets is in 2930 Brasschaat.
What is the equity of Dr. de Weerd Pets?
At the close of the 2025 financial year, the equity of Dr. de Weerd Pets amounts to 428,870 €, a solvency of 51.3% of total assets.
Who manages Dr. de Weerd Pets?
The register lists 1 active mandates at Dr. de Weerd Pets. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. de Weerd Pets
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →